Cancer risks in BRCA1 carriers: time for the next generation of studies

Discovery and Validation of Methylated DNA Markers From Pancreatic Neuroendocrine Tumors.

Gastro hep advances·2024

Polycyclic Aromatic Hydrocarbons and Pancreatic Cancer: An Analysis of the Blood Biomarker, r-1,t-2,3,c-4-Tetrahydroxy-1,2,3,4-tetrahydrophenanthrene and Selected Metabolism Gene SNPs.

Nutrients·2024

A Randomized Trial of Two Remote Health Care Delivery Models on the Uptake of Genetic Testing and Impact on Patient-Reported Psychological Outcomes in Families With Pancreatic Cancer: The Genetic Education, Risk Assessment, and Testing (GENERATE) Study.

Gastroenterology·2024

Risk of Syndrome-Associated Cancers Among First-Degree Relatives of Patients With Pancreatic Ductal Adenocarcinoma With Pathogenic or Likely Pathogenic Germline Variants.

JAMA oncology·2023

Culture media composition influences patient-derived organoid ability to predict therapeutic responses in gastrointestinal cancers.

JCI insight·2022

Tissue methylated DNA markers for sporadic pancreatic cancer are strongly associated with familial and genetically predisposed pancreatic cancer.

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]·2022

A phase II randomized study of proton therapy vs intensity-modulated radiation therapy in patients with unilateral head and neck cancer.

Journal of the National Cancer Institute·2026

Cancer rarity and mortality: Evidence from a nationwide cohort study.

Journal of the National Cancer Institute·2026

Matched targeted therapy use after broad genomic profiling in advanced Non-Small cell lung cancer.

Journal of the National Cancer Institute·2026

Evaluating the incidence and predictors of chronic opioid use in early survivorship for patients with diffuse large B-cell lymphoma.

Journal of the National Cancer Institute·2026

Predictive validity of a 10-item frailty index based on a comprehensive geriatric assessment (FI-CGA-10) in older Japanese adults with cancer.

Journal of the National Cancer Institute·2026

Association between genomic classifier scores and initial management of localized prostate cancer in the United States.

Journal of the National Cancer Institute·2026

Cirrhosis severity modulates proteomic and immune landscapes in hepatocellular carcinoma.

Npj gut and liver·2026

Hereditary leiomyomatosis and renal cell carcinoma: a case report and literature review.

Frontiers in urology·2026

Serum DIP2C protein concentration in human colorectal cancer among Yemeni patients.

Frontiers in oncology·2026

A Novel BRCA1 Pathogenic Variant in Tunisian Patient With High Grade Ovarian Cancer: Favorable Therapeutic Response to Olaparib.

Cancer reports (Hoboken, N.J.)·2026

Prevalence of BRCA1/2 variants in an Ovarian Cancer Cohort: outcomes from a Nationwide Testing Program.

European journal of human genetics : EJHG·2026

Functional coupling between MC4R and Kir7.1 contributes to clozapine-induced weight gain in female mice.

Nature communications·2026

Related Experiment Videos

Cancer risks in BRCA1 carriers: time for the next generation of studies

Related Concept Videos

Discovery and Validation of Methylated DNA Markers From Pancreatic Neuroendocrine Tumors.

Polycyclic Aromatic Hydrocarbons and Pancreatic Cancer: An Analysis of the Blood Biomarker, r-1,t-2,3,c-4-Tetrahydroxy-1,2,3,4-tetrahydrophenanthrene and Selected Metabolism Gene SNPs.

A Randomized Trial of Two Remote Health Care Delivery Models on the Uptake of Genetic Testing and Impact on Patient-Reported Psychological Outcomes in Families With Pancreatic Cancer: The Genetic Education, Risk Assessment, and Testing (GENERATE) Study.

Risk of Syndrome-Associated Cancers Among First-Degree Relatives of Patients With Pancreatic Ductal Adenocarcinoma With Pathogenic or Likely Pathogenic Germline Variants.

Culture media composition influences patient-derived organoid ability to predict therapeutic responses in gastrointestinal cancers.

Tissue methylated DNA markers for sporadic pancreatic cancer are strongly associated with familial and genetically predisposed pancreatic cancer.

A phase II randomized study of proton therapy vs intensity-modulated radiation therapy in patients with unilateral head and neck cancer.

Cancer rarity and mortality: Evidence from a nationwide cohort study.

Matched targeted therapy use after broad genomic profiling in advanced Non-Small cell lung cancer.

Evaluating the incidence and predictors of chronic opioid use in early survivorship for patients with diffuse large B-cell lymphoma.

Predictive validity of a 10-item frailty index based on a comprehensive geriatric assessment (FI-CGA-10) in older Japanese adults with cancer.

Association between genomic classifier scores and initial management of localized prostate cancer in the United States.

Cirrhosis severity modulates proteomic and immune landscapes in hepatocellular carcinoma.

Hereditary leiomyomatosis and renal cell carcinoma: a case report and literature review.

Serum DIP2C protein concentration in human colorectal cancer among Yemeni patients.

A Novel BRCA1 Pathogenic Variant in Tunisian Patient With High Grade Ovarian Cancer: Favorable Therapeutic Response to Olaparib.

Prevalence of BRCA1/2 variants in an Ovarian Cancer Cohort: outcomes from a Nationwide Testing Program.

Functional coupling between MC4R and Kir7.1 contributes to clozapine-induced weight gain in female mice.

Related Experiment Videos

Cancer risks in BRCA1 carriers: time for the next generation of studies

Related Concept Videos

Related Articles